Welch Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$575K Sell
2,586
-107
-4% -$24.9K 0.02% 182
2026
Q2
$640K Hold
2,693
– – 0.02% 167
2026
Q1
$569K Buy
2,693
+33
+1% +$7.11K 0.02% 167
2025
Q4
$547K Buy
2,660
+1,132
+74% +$213K 0.02% 165
2025
Q3
$240K Sell
1,528
-42
-3% -$6.49K 0.01% 264
2025
Q2
$264K Buy
1,570
+42
+3% +$6.23K 0.01% 219
2025
Q1
$208K Buy
+1,528
New +$195K 0.01% 241

Other funds holding CAH

Welch Group's CAH Position: Q3 2026 in Review

Welch Group reduced its Cardinal Health (CAH) stake by 4% in Q3 2026, selling an estimated $24.9K and leaving 2,586 shares worth $575K. The position accounts for 0.02% of the portfolio, ranked #182.

Welch Group first reported a position in CAH in Q1 2025 and has held it in 7 quarters since. The position peaked at $640K in Q2 2026. 529 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Welch Group held 2,586 shares of Cardinal Health worth $575K as of Q3 2026.
  • Welch Group sold 107 Cardinal Health shares in Q3 2026, an estimated $24.9K.
  • Cardinal Health made up 0.02% of Welch Group's portfolio in Q3 2026, its #182 holding.
  • Welch Group first reported a position in Cardinal Health in Q1 2025 and has held it in 7 quarters since.
  • Welch Group's Cardinal Health position peaked at $640K in Q2 2026.
  • 529 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Welch Group's 13F filing for Q3 2026, filed 29 Oct 2026.